As dysregulation of miRNAs is observed in T1DM pathogenesis, restoring these miRNAs back to normal levels and using miRNA mimics or inhibitors could improve insulin production and secretion, as well as insulin sensitivity. This evidence concerns the gene INS and type 1 diabetes mellitus.